BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Narayanaswami V, Dwoskin LP. Obesity: Current and potential pharmacotherapeutics and targets. Pharmacol Ther 2017;170:116-47. [PMID: 27773782 DOI: 10.1016/j.pharmthera.2016.10.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Altaf A, Abbas MM. Public perception of bariatric surgery. Saudi Med J 2019;40:379-84. [PMID: 30957132 DOI: 10.15537/smj.2019.4.24050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Woodard K, Louque L, Hsia DS. Medications for the treatment of obesity in adolescents. Therapeutic Advances in Endocrinology 2020;11:204201882091878. [DOI: 10.1177/2042018820918789] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
3 Modesto ACF, Silveira EA, dos Santos Rodrigues AP, Lima DM, Provin MP, Amaral RG. Prevalence of Drug Interaction in Severely Obese Individuals and Associated Factors: Baseline Results from a Clinical Trial. Sci Pharm 2020;88:48. [DOI: 10.3390/scipharm88040048] [Reference Citation Analysis]
4 Li B, Hong Y, Gu Y, Ye S, Hu K, Yao J, Ding K, Zhao A, Jia W, Li H. Functional Metabolomics Reveals that Astragalus Polysaccharides Improve Lipids Metabolism through Microbial Metabolite 2-Hydroxybutyric Acid in Obese Mice. Engineering 2020. [DOI: 10.1016/j.eng.2020.05.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Li J, Cha R, Luo H, Hao W, Zhang Y, Jiang X. Nanomaterials for the theranostics of obesity. Biomaterials 2019;223:119474. [PMID: 31536920 DOI: 10.1016/j.biomaterials.2019.119474] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ma L, Hou X, Qin X, He R, Yu H, Hu Q, Guan X, Jia S, Hou J, Lei T, Ge G. Discovery of human pancreatic lipase inhibitors from root of Rhodiola Crenulata via integrating bioactivity-guided fractionation, chemical profiling and biochemical assay. Journal of Pharmaceutical Analysis 2022. [DOI: 10.1016/j.jpha.2022.04.002] [Reference Citation Analysis]
7 Cho Y, Park J, Kang HJ, Kim W, Cho MJ, Jang J, Kwon M, Kim S, Lee S, Lee J, Kim Y, Park Y, Kim WK, Bae K, Kwon B, Chung SJ, Min J. Ginkgetin, a biflavone from Ginkgo biloba leaves, prevents adipogenesis through STAT5-mediated PPARγ and C/EBPα regulation. Pharmacological Research 2019;139:325-36. [DOI: 10.1016/j.phrs.2018.11.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
8 Hao L, Kearns J, Scott S, Wu D, Kodani SD, Morisseau C, Hammock BD, Sun X, Zhao L, Wang S. Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 2018;365:467-75. [PMID: 29567865 DOI: 10.1124/jpet.117.246256] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Gaspar JM, Velloso LA. Hypoxia Inducible Factor as a Central Regulator of Metabolism - Implications for the Development of Obesity. Front Neurosci 2018;12:813. [PMID: 30443205 DOI: 10.3389/fnins.2018.00813] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
10 Haghbin H, Gangwani MK, Ravi SJK, Perisetti A, Aziz M, Goyal H, Nawras A, Sodeman T. Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions. Ann Gastroenterol 2020;33:603-14. [PMID: 33162737 DOI: 10.20524/aog.2020.0550] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Glass J, Chaudhry A, Zeeshan MS, Ramzan Z. New Era: Endoscopic treatment options in obesity–a paradigm shift. World J Gastroenterol 2019; 25(32): 4567-4579 [PMID: 31528087 DOI: 10.3748/wjg.v25.i32.4567] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
12 Vezza T, Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, Romero M, Sánchez M, Toral M, Martín-García B, Gómez-Caravaca AM, Arráez-Román D, Segura-Carretero A, Micol V, García F, Utrilla MP, Duarte J, Rodríguez-Cabezas ME, Gálvez J. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties. Pharmacol Res 2019;150:104487. [PMID: 31610229 DOI: 10.1016/j.phrs.2019.104487] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
13 Moore MC, Coate KC, Scott M, Kraft G, Vath JE, Hughes TE, Farmer B, Cherrington AD. MetAP2 inhibitor treatment of high-fat and -fructose-fed dogs: impact on the response to oral glucose ingestion and a hyperinsulinemic hyperglycemic clamp. Am J Physiol Endocrinol Metab 2020;318:E514-24. [PMID: 31990576 DOI: 10.1152/ajpendo.00451.2019] [Reference Citation Analysis]
14 Ren J, Wu NN, Wang S, Sowers JR, Zhang Y. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev 2021;101:1745-807. [PMID: 33949876 DOI: 10.1152/physrev.00030.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Li Y, Li X, Yu L, Wang L, Shi Z, Guo X. Roles of galectin-3 in metabolic disorders and tumor cell metabolism. International Journal of Biological Macromolecules 2020;142:463-73. [DOI: 10.1016/j.ijbiomac.2019.09.118] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
16 Volkow ND, Wise RA, Baler R. The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci 2017;18:741-52. [DOI: 10.1038/nrn.2017.130] [Cited by in Crossref: 332] [Cited by in F6Publishing: 281] [Article Influence: 66.4] [Reference Citation Analysis]
17 Abedimanesh N, Bathaie SZ, Abedimanesh S, Motlagh B, Separham A, Ostadrahimi A. Saffron and crocin improved appetite, dietary intakes and body composition in patients with coronary artery disease. J Cardiovasc Thorac Res 2017;9:200-8. [PMID: 29391933 DOI: 10.15171/jcvtr.2017.35] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
18 Park SJ, Yu Y, Zides CG, Beyak MJ. Mechanisms of reduced leptin-mediated satiety signaling during obesity. Int J Obes (Lond) 2022. [PMID: 35241786 DOI: 10.1038/s41366-022-01079-2] [Reference Citation Analysis]
19 Liu Z, Zhang Y, Zhao T, Wang J, Xia L, Zhong Y, Yang Y, Ning X, Zhang Y, Ren Z, Liu H. A higher body mass index in Chinese inpatients with chronic schizophrenia is associated with elevated plasma orexin-A levels and fewer negative symptoms. Nordic Journal of Psychiatry 2020;74:525-32. [DOI: 10.1080/08039488.2020.1755995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lee JK, Lee JJ, Kim YK, Lee Y, Ha JH. Stachys sieboldii Miq. Root Attenuates Weight Gain and Dyslipidemia in Rats on a High-Fat and High-Cholesterol Diet. Nutrients 2020;12:E2063. [PMID: 32664607 DOI: 10.3390/nu12072063] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hsu TM, Noble EE, Liu CM, Cortella AM, Konanur VR, Suarez AN, Reiner DJ, Hahn JD, Hayes MR, Kanoski SE. A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling. Mol Psychiatry 2018;23:1555-65. [PMID: 28461695 DOI: 10.1038/mp.2017.91] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 10.2] [Reference Citation Analysis]
22 Zhou J, Mao L, Xu P, Wang Y. Effects of (-)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet. Nutrients 2018;10:E1681. [PMID: 30400620 DOI: 10.3390/nu10111681] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
23 Peña-Romero AC, Navas-Carrillo D, Marín F, Orenes-Piñero E. The future of nutrition: Nutrigenomics and nutrigenetics in obesity and cardiovascular diseases. Crit Rev Food Sci Nutr 2018;58:3030-41. [PMID: 28678615 DOI: 10.1080/10408398.2017.1349731] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
24 Meneguetti BT, Cardoso MH, Ribeiro CF, Felício MR, Pinto IB, Santos NC, Carvalho CM, Franco OL. Neuropeptide receptors as potential pharmacological targets for obesity. Pharmacology & Therapeutics 2019;196:59-78. [DOI: 10.1016/j.pharmthera.2018.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
25 Xu L, Lin W, Zheng Y, Chen J, Fang Z, Tan N, Hu W, Guo Y, Wang Y, Chen Z. An H2R-dependent medial septum histaminergic circuit mediates feeding behavior. Curr Biol 2022:S0960-9822(22)00401-8. [PMID: 35338850 DOI: 10.1016/j.cub.2022.03.010] [Reference Citation Analysis]
26 Wang H, Wang L, Cheng Y, Xia Z, Liao Y, Cao J. Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Biomed Rep 2018;9:90-6. [PMID: 29930810 DOI: 10.3892/br.2018.1100] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
27 Liu X, Gao S, Zhang N, Jin T, Sun X, Luan X, Xu L, Guo F. The orexinergic neural pathway from the lateral hypothalamus to the nucleus accumbens and its regulation of palatable food intake. Neuropeptides 2020;80:102028. [PMID: 32067750 DOI: 10.1016/j.npep.2020.102028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
28 Koncz D, Tóth B, Roza O, Csupor D. A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss. Front Pharmacol 2020;11:611361. [PMID: 33574758 DOI: 10.3389/fphar.2020.611361] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
29 Singhal V, Sella AC, Malhotra S. Pharmacotherapy in pediatric obesity: current evidence and landscape. Curr Opin Endocrinol Diabetes Obes 2021;28:55-63. [PMID: 33186194 DOI: 10.1097/MED.0000000000000587] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 García-Cárceles J, Decara JM, Vázquez-Villa H, Rodríguez R, Codesido E, Cruces J, Brea J, Loza MI, Alén F, Botta J, McCormick PJ, Ballesteros JA, Benhamú B, Rodríguez de Fonseca F, López-Rodríguez ML. A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity. J Med Chem 2017;60:9575-84. [PMID: 29116785 DOI: 10.1021/acs.jmedchem.7b00994] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
31 Modesto ACF, Silveira EA, Santos ASEADC, Rodrigues APDS, Lima DM, Provin MP, Amaral RG. Prevalence of Adverse Drug Events in Severely Obese Adults and Associated Factors: Clinical Trial Baseline Results. Sci Pharm 2020;88:41. [DOI: 10.3390/scipharm88040041] [Reference Citation Analysis]
32 Peng Y, Zhao S, Wu Y, Cao H, Xu Y, Liu X, Shui W, Cheng J, Zhao S, Shen L, Ma J, Quinn RJ, Stevens RC, Zhong G, Liu ZJ. Identification of natural products as novel ligands for the human 5-HT2C receptor. Biophys Rep 2018;4:50-61. [PMID: 29577069 DOI: 10.1007/s41048-018-0047-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
33 Payab M, Goodarzi P, Foroughi Heravani N, Hadavandkhani M, Zarei Z, Falahzadeh K, Larijani B, Rahim F, Arjmand B. Stem Cell and Obesity: Current State and Future Perspective. In: Turksen K, editor. Cell Biology and Translational Medicine, Volume 2. Cham: Springer International Publishing; 2018. pp. 1-22. [DOI: 10.1007/5584_2018_227] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
34 Wan Y, Xia J, Xu JF, Chen L, Yang Y, Wu JJ, Tang F, Ao H, Peng C. Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases. Pharmacol Res 2021;175:106002. [PMID: 34826599 DOI: 10.1016/j.phrs.2021.106002] [Reference Citation Analysis]
35 Li S, Wang L, Liu B, He N. Unsaturated alginate oligosaccharides attenuated obesity-related metabolic abnormalities by modulating gut microbiota in high-fat-diet mice. Food Funct 2020;11:4773-84. [DOI: 10.1039/c9fo02857a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
36 Rahman TM, Fleifel D, Padela MT, Anoushiravani A, Rizvi SA, El-Othmani MM, Sayeed Z. Interventions for Obesity and Nutritional Status in Arthroplasty Patients. JBJS Rev 2020;8:e0161. [PMID: 32224637 DOI: 10.2106/JBJS.RVW.19.00161] [Reference Citation Analysis]
37 Xu Y, Sromek AW, Neumeyer JL. Identification of fluorinated (R)-(−)-aporphine derivatives as potent and selective ligands at serotonin 5-HT2C receptor. Bioorganic & Medicinal Chemistry Letters 2019;29:230-3. [DOI: 10.1016/j.bmcl.2018.11.050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Xu Z, Liu D, Liu D, Ren X, Liu H, Qi G, Zhou Y, Wu C, Zhu K, Zou Z, Yuan J, Lin W, Guo P. Equisetin is an anti-obesity candidate through targeting 11β-HSD1. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.01.006] [Reference Citation Analysis]
39 Wu Y, He H, Cheng Z, Bai Y, Ma X. The role of neuropeptide Y and peptide YY in the development of obesity via gut-brain axis. Curr Protein Pept Sci. 2019;20:750-758. [PMID: 30678628 DOI: 10.2174/1389203720666190125105401] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
40 Pai SA, Martis EA, Munshi RP, Gursahani MS, Mestry SN, Juvekar AR. Chrysin mitigated obesity by regulating energy intake and expenditure in rats. J Tradit Complement Med 2020;10:577-85. [PMID: 33134134 DOI: 10.1016/j.jtcme.2019.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
41 Dahl K, Nakao R, Amini N, Moein MM, Finnema S, Malmquist J, Varnäs K, Schou M. Development of [ Carbonyl-11C]AZ13198083, a Novel Histamine Type-3 Receptor Radioligand with Favorable Kinetics. ACS Chem Neurosci 2018;9:906-11. [PMID: 29359917 DOI: 10.1021/acschemneuro.7b00493] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
42 Llaha F, Zamora-Ros R. The Effects of Polyphenol Supplementation in Addition to Calorie Restricted Diets and/or Physical Activity on Body Composition Parameters: A Systematic Review of Randomized Trials. Front Nutr 2020;7:84. [PMID: 32582757 DOI: 10.3389/fnut.2020.00084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
43 Liu X, Zhao K, Jing N, Kong Q, Yang X. Epigallocatechin Gallate (EGCG) Promotes the Immune Function of Ileum in High Fat Diet Fed Mice by Regulating Gut Microbiome Profiling and Immunoglobulin Production. Front Nutr 2021;8:720439. [PMID: 34616764 DOI: 10.3389/fnut.2021.720439] [Reference Citation Analysis]
44 Freitas RDS, Campos MM. Understanding the appetite modulation pathways: The role of the FFA1 and FFA4 receptors. Biochem Pharmacol 2021;186:114503. [PMID: 33711286 DOI: 10.1016/j.bcp.2021.114503] [Reference Citation Analysis]
45 Shen S, Liao Q, Lyu M, Wong YK, Zhang X, Zhou J, Ma N, Wang J. The potential of artemisinins as anti-obesity agents via modulating the immune system. Pharmacol Ther 2020;216:107696. [PMID: 33022301 DOI: 10.1016/j.pharmthera.2020.107696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
46 Liu X, Zhao K, Jing N, Zhao Y, Yang X. EGCG regulates fatty acid metabolism of high-fat diet-fed mice in association with enrichment of gut Akkermansia muciniphila. Journal of Functional Foods 2020;75:104261. [DOI: 10.1016/j.jff.2020.104261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
47 Huang D, Deng M, Kuang S. Polymeric Carriers for Controlled Drug Delivery in Obesity Treatment. Trends Endocrinol Metab 2019;30:974-89. [PMID: 31668904 DOI: 10.1016/j.tem.2019.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
48 Ray A. Cancer and comorbidity: The role of leptin in breast cancer and associated pathologies. World J Clin Cases 2018; 6(12): 483-492 [PMID: 30397604 DOI: 10.12998/wjcc.v6.i12.483] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
49 Alruwaili H, Dehestani B, le Roux CW. Clinical Impact of Liraglutide as a Treatment of Obesity. Clin Pharmacol 2021;13:53-60. [PMID: 33732030 DOI: 10.2147/CPAA.S276085] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Pilitsi E, Farr OM, Polyzos SA, Perakakis N, Nolen-Doerr E, Papathanasiou AE, Mantzoros CS. Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism 2019;92:170-92. [PMID: 30391259 DOI: 10.1016/j.metabol.2018.10.010] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 17.5] [Reference Citation Analysis]
51 Wang J, He W, Yang D, Cao H, Bai Y, Guo J, Su Z. Beneficial Metabolic Effects of Chitosan and Chitosan Oligosaccharide on Epididymal WAT Browning and Thermogenesis in Obese Rats. Molecules 2019;24:E4455. [PMID: 31817377 DOI: 10.3390/molecules24244455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
52 Chaturvedi S, Gupta P. Evaluation of Bioactive Metabolites and Antioxidant-Rich Extracts of Amaranths with Possible Role in Pancreatic Lipase Interaction: In Silico and In Vitro Studies. Metabolites 2021;11:676. [PMID: 34677391 DOI: 10.3390/metabo11100676] [Reference Citation Analysis]
53 Du Z, Li J, Huang J, Ma J, Xu X, Zou R, Xu X. Executive Functions in Predicting Weight Loss and Obesity Indicators: A Meta-Analysis. Front Psychol 2020;11:604113. [PMID: 33584440 DOI: 10.3389/fpsyg.2020.604113] [Reference Citation Analysis]
54 Nikou AF, Lai M, Solmssen C, Bhargava M, Ben-David K, Ramsubick C, Rice T, Coffey B. Topiramate for Posttraumatic Symptoms in an Obese Adolescent Girl. J Child Adolesc Psychopharmacol 2021;31:235-41. [PMID: 33890820 DOI: 10.1089/cap.2021.29199.bjc] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Montan PD, Sourlas A, Olivero J, Silverio D, Guzman E, Kosmas CE. Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Ann Transl Med 2019;7:393. [PMID: 31555707 DOI: 10.21037/atm.2019.07.27] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
56 Briand F, Brousseau E, Maupoint J, Dubroca C, Costard C, Breyner N, Burcelin R, Sulpice T. Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model. European Journal of Pharmacology 2020;882:173316. [DOI: 10.1016/j.ejphar.2020.173316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Higuera-Hernández MF, Reyes-Cuapio E, Gutiérrez-Mendoza M, Rocha NB, Veras AB, Budde H, Jesse J, Zaldívar-Rae J, Blanco-Centurión C, Machado S, Murillo-Rodríguez E. Fighting obesity: Non-pharmacological interventions. Clin Nutr ESPEN 2018;25:50-5. [PMID: 29779818 DOI: 10.1016/j.clnesp.2018.04.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
58 Dourish CT, Clifton PG. Multidisciplinary approaches to the study of eating disorders and obesity: Recent progress in research and development and future prospects. J Psychopharmacol 2017;31:1383-7. [PMID: 29157103 DOI: 10.1177/0269881117740779] [Reference Citation Analysis]
59 Feng J, Zhang X, Shan C, Xia J, Zhang Z, Shi H, Leng K, Wu Y, Ji C, Zhong T. Src family kinases involved in the differentiation of human preadipocytes. Mol Cell Endocrinol 2021;533:111323. [PMID: 34000351 DOI: 10.1016/j.mce.2021.111323] [Reference Citation Analysis]
60 Moore CF, Schlain GS, Mancino S, Sabino V, Cottone P. A behavioral and pharmacological characterization of palatable diet alternation in mice. Pharmacol Biochem Behav 2017;163:1-8. [PMID: 29097161 DOI: 10.1016/j.pbb.2017.10.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
61 Higgs S, Spetter MS, Thomas JM, Rotshtein P, Lee M, Hallschmid M, Dourish CT. Interactions between metabolic, reward and cognitive processes in appetite control: Implications for novel weight management therapies. J Psychopharmacol 2017;31:1460-74. [PMID: 29072515 DOI: 10.1177/0269881117736917] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
62 Nakamura T, Tanimoto H, Mizuno Y, Okamoto M, Takeuchi M, Tsubamoto Y, Noda H. Gastric inhibitory polypeptide receptor antagonist, SKL-14959, suppressed body weight gain on diet-induced obesity mice. Obes Sci Pract 2018;4:194-203. [PMID: 29670757 DOI: 10.1002/osp4.164] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
63 Boles A, Kandimalla R, Reddy PH. Dynamics of diabetes and obesity: Epidemiological perspective. Biochim Biophys Acta Mol Basis Dis. 2017;1863:1026-1036. [PMID: 28130199 DOI: 10.1016/j.bbadis.2017.01.016] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 15.0] [Reference Citation Analysis]
64 Rosa-Gonçalves P, Majerowicz D. Pharmacotherapy of Obesity: Limits and Perspectives. Am J Cardiovasc Drugs 2019;19:349-64. [PMID: 30793263 DOI: 10.1007/s40256-019-00328-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
65 Cifuentes L, Acosta A. Homeostatic regulation of food intake. Clin Res Hepatol Gastroenterol 2021;46:101794. [PMID: 34481092 DOI: 10.1016/j.clinre.2021.101794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Kusyk DM, Whiting D. Responsive deep brain stimulation and obesity: Commentary on a developing technology. Obesity (Silver Spring) 2022;30:297. [PMID: 35088554 DOI: 10.1002/oby.23351] [Reference Citation Analysis]
67 Mao Q, Zhang B, Li W, Tian S, Shui W, Ye N. Identification of Novel 1-O-Substituted Aporphine Analogues as Potent 5-HT2C Receptor Agonists. ACS Chem Neurosci 2020;11:549-59. [PMID: 31968160 DOI: 10.1021/acschemneuro.9b00563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
68 Yadav MR, Murumkar PR. Advances in patented CB1 receptor antagonists for obesity. Pharm Pat Anal 2018;7:169-73. [PMID: 30066594 DOI: 10.4155/ppa-2018-0020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
69 Matsushita K, Dzau VJ. Mesenchymal stem cells in obesity: insights for translational applications. Lab Invest 2017;97:1158-66. [PMID: 28414326 DOI: 10.1038/labinvest.2017.42] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
70 Page LC, Shi M, Freemark M. Early-Onset Obesity Caused by Monogenic Disorders. Curr Pediatr Rep 2017;5:100-10. [DOI: 10.1007/s40124-017-0132-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
71 Eiler WJA 2nd, Gleason SD, Smith JL, Witkin JM. A medium throughput rodent model of relapse from addiction with behavioral and pharmacological specificity. Pharmacol Biochem Behav 2019;183:72-9. [PMID: 31202811 DOI: 10.1016/j.pbb.2019.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Schellekens H, Torres-Fuentes C, van de Wouw M, Long-Smith CM, Mitchell A, Strain C, Berding K, Bastiaanssen TFS, Rea K, Golubeva AV, Arboleya S, Verpaalen M, Pusceddu MM, Murphy A, Fouhy F, Murphy K, Ross P, Roy BL, Stanton C, Dinan TG, Cryan JF. Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to human. EBioMedicine 2021;63:103176. [PMID: 33349590 DOI: 10.1016/j.ebiom.2020.103176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
73 Zhang C, Zhang B, Zhang X, Sun G, Sun X. Targeting Orphan Nuclear Receptors NR4As for Energy Homeostasis and Diabetes. Front Pharmacol 2020;11:587457. [PMID: 33328994 DOI: 10.3389/fphar.2020.587457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
74 Nani A, Murtaza B, Sayed Khan A, Khan NA, Hichami A. Antioxidant and Anti-Inflammatory Potential of Polyphenols Contained in Mediterranean Diet in Obesity: Molecular Mechanisms. Molecules 2021;26:985. [PMID: 33673390 DOI: 10.3390/molecules26040985] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
75 Qin S, Meng M, Yang D, Bai W, Lu Y, Peng Y, Song G, Wu Y, Zhou Q, Zhao S, Huang X, McCorvy JD, Cai X, Dai A, Roth BL, Hanson MA, Liu ZJ, Wang MW, Stevens RC, Shui W. High-throughput identification of G protein-coupled receptor modulators through affinity mass spectrometry screening. Chem Sci 2018;9:3192-9. [PMID: 29732102 DOI: 10.1039/c7sc04698g] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
76 Rufino AT, Costa VM, Carvalho F, Fernandes E. Flavonoids as antiobesity agents: A review. Med Res Rev 2021;41:556-85. [PMID: 33084093 DOI: 10.1002/med.21740] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
77 Aderibigbe AO, Pandey P, Doerksen RJ. Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569. J Biomol Struct Dyn 2021;:1-19. [PMID: 33480332 DOI: 10.1080/07391102.2021.1873187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Carpentier AC, Blondin DP, Virtanen KA, Richard D, Haman F, Turcotte ÉE. Brown Adipose Tissue Energy Metabolism in Humans. Front Endocrinol (Lausanne) 2018;9:447. [PMID: 30131768 DOI: 10.3389/fendo.2018.00447] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 24.8] [Reference Citation Analysis]